161 related articles for article (PubMed ID: 6444543)
21. Kinetic analysis of 5-fluorouracil action against various cancer cells.
Inaba M; Mitsuhashi J; Ozawa S
Jpn J Cancer Res; 1990 Oct; 81(10):1039-44. PubMed ID: 2146239
[TBL] [Abstract][Full Text] [Related]
22. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
Iigo M; Hoshi A
Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
[TBL] [Abstract][Full Text] [Related]
23. Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorin in murine colon carcinomas.
Van Laar JA; Rustum YM; Van der Wilt CL; Smid K; Kuiper CM; Pinedo HM; Peters GJ
Cancer Chemother Pharmacol; 1996; 39(1-2):79-89. PubMed ID: 8995503
[TBL] [Abstract][Full Text] [Related]
24. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS
Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.
Liu C; Willingham M; Liu J; Gmeiner WH
Int J Oncol; 2002 Aug; 21(2):303-8. PubMed ID: 12118325
[TBL] [Abstract][Full Text] [Related]
26. Binding of 5-fluorodeoxyuridylate to thymidylate synthase in human colon adenocarcinoma xenografts.
Houghton JA; Torrance PM; Radparvar S; Williams LG; Houghton PJ
Eur J Cancer Clin Oncol; 1986 Apr; 22(4):505-10. PubMed ID: 3732354
[TBL] [Abstract][Full Text] [Related]
27. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
28. Potentiation by dipyridamole of 5-fluorouridine antitumor activity against a rat adenocarcinoma in vivo.
el Hag IA; Roos G; Jönsson PE; Stenram U
Anticancer Res; 1990; 10(1):29-32. PubMed ID: 2139770
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
[TBL] [Abstract][Full Text] [Related]
30. Studies on 18F-labeled pyrimidines. II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2'-deoxyuridine and 18F-5-fluorouridine in rats.
Ishiwata K; Ido T; Kawashima K; Murakami M; Takahashi T
Eur J Nucl Med; 1984; 9(4):185-9. PubMed ID: 6232143
[TBL] [Abstract][Full Text] [Related]
31. Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; de Graaf SS; Cheshire PJ; Rodman JH; Maneval DC; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jun; 50(12):3493-502. PubMed ID: 2140289
[TBL] [Abstract][Full Text] [Related]
32. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
[TBL] [Abstract][Full Text] [Related]
33. Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.
Houghton PJ; Houghton JA; Hazelton BJ; Radparvar S
Invest New Drugs; 1989 Apr; 7(1):59-69. PubMed ID: 2661484
[TBL] [Abstract][Full Text] [Related]
34. Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice.
Ishiwata K; Ido T; Abe Y; Matsuzawa T; Murakami M
Eur J Nucl Med; 1985; 10(1-2):39-44. PubMed ID: 3156740
[TBL] [Abstract][Full Text] [Related]
35. The effects of the fluorinated pyrimidines FUR, FUdR, FUMP, and FdUMP on human Tenon's fibroblasts.
Lee DA; Shapourifar-Tehrani S; Stephenson TR; Kitada S
Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2599-609. PubMed ID: 1831188
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.
Carli D; Honorat M; Cohen S; Megherbi M; Vignal B; Dumontet C; Payen L; Guitton J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2937-44. PubMed ID: 19620028
[TBL] [Abstract][Full Text] [Related]
37. Antagonistic effect of polyinosinic-polycytidylic acid on the cell lethality produced by 5-fluorouracil in human colon carcinoma cells in vitro.
Iigo M; Glazer RI
Cancer Res; 1985 May; 45(5):1953-7. PubMed ID: 2580613
[TBL] [Abstract][Full Text] [Related]
38. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
[TBL] [Abstract][Full Text] [Related]
39. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.
Link KH; Aigner KR; Peschau K; Warthona M; Schwemmle K; Danenberg PV
Cancer Chemother Pharmacol; 1988; 22(1):58-62. PubMed ID: 2969305
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
